Aurubis (ETR:NDA) has been assigned a €90.00 ($111.11) target price by research analysts at Nord/LB in a research note issued to investors on Thursday. The firm presently has a “buy” rating on the stock. Nord/LB’s price objective would indicate a potential upside of 21.85% from the company’s previous close.
Other equities analysts have also recently issued reports about the stock. Kepler Capital Markets set a €90.00 ($111.11) price objective on shares of Aurubis and gave the stock a “buy” rating in a research report on Tuesday, December 5th. Warburg Research set a €84.00 ($103.70) price objective on shares of Aurubis and gave the stock a “buy” rating in a research report on Monday, December 11th. Finally, Hauck & Aufhaeuser set a €83.00 ($102.47) price objective on shares of Aurubis and gave the stock a “buy” rating in a research report on Tuesday, October 24th. Six research analysts have rated the stock with a sell rating, six have assigned a hold rating and four have given a buy rating to the company. Aurubis presently has an average rating of “Hold” and an average price target of €73.94 ($91.29).
Aurubis (NDA) traded down €0.80 ($0.99) during trading hours on Thursday, reaching €73.86 ($91.19). 230,433 shares of the company’s stock were exchanged, compared to its average volume of 238,967. The firm has a market capitalization of $3,320.00 and a PE ratio of 8.24. Aurubis has a 52 week low of €53.45 ($65.99) and a 52 week high of €86.80 ($107.16).
Aurubis AG engages in the copper concentrate processing, metal recycling, and copper product fabrication activities in Europe, Asia, the United States, and internationally. It operates in two segments, Primary Copper and Copper Products. The company procures and processes copper concentrates; produces and markets exchange-traded copper cathodes; and produces and markets sulfuric acid, iron silicate, precious metals, and specialty products.
Receive News & Ratings for Aurubis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurubis and related companies with MarketBeat.com's FREE daily email newsletter.